A global multi-billion dollar market with a significant need for more efficacious and safer therapeutic options for patients with inflammatory diseases

Inflammatory Conditions in Need of Improved Therapies

All of the potential indications being developed by Carocell Bio are serious healthcare issues and have high medical need and market potential. Scar prevention, Atopic Dermatitis (AD), Ageing / Senescence, Dry Eye Disease (DED), Burns, Inflammatory Bowel Disease (IBD) and Epidermolysis Bullosa (EB) are significant challenges in Human Health with enormous market potential and Carocell Bio has the possibility of delivering truly innovative new medicines to this market.

3 Key Therapy Areas we are focusing on

Scar Prevention and Post-Operative Treatment

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.


New medicines with anti-microbial and wound healing properties as well as anti-inflammatory and analgesic properties.

atopic dermatitis

Using a potent, selective inhibitor, together with our effective bacteriocidal nanopolymer delivery system this treatment will address two of the three key mechanisms of AD.

INVEST IN Carocell Bio

We are seeking a phased $10 million ‘Series A’ investment over the next 3 years to take the lead compound through to approved IND/CTA. Find out how you can play a part in our success


Find out more about our therapeutic peptides and how they can reduce inflammation in a host of serious inflammatory diseases.


Download and share our documentation